Historical record - last NADAC publication: 1/22/2020
Product Information
TAMIFLU 30 MG CAPSULE is a brand product labeled by Genentech, Inc., priced at $13.3994 per EA under NDC 00004080285. Its NADAC has been published 373 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the oseltamivir phosphate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Genentech, Inc.NDC
00004080285
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
1/22/2020
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
New Drug (NDA)
FDA Application
NDA021087On Market Since
10/27/1999
Pharmacological Classes
Price Statistics
The NADAC for TAMIFLU 30 MG CAPSULE has been published 373 times since Nov 28, 2013, and over the history we have for it it has risen 37.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.3994 per EA |
|---|---|
| All-time high | $13.4165 (Mar 13, 2019) |
| All-time low | $9.4158 (Jun 18, 2014) |
| Median price | $12.6454 |
| Average price | $12.3197 |
| Largest weekly change | +9.0% (Jul 9, 2014) |
| Weeks tracked | 373 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TAMIFLU 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TAMIFLU 30 MG CAPSULE, manufactured by Genentech, Inc., is $13.3994 per EA (NDC 00004080285), effective Jan 13, 2021.
How has the price of TAMIFLU 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TAMIFLU 30 MG CAPSULE has risen 37.7%. It has been tracked across 373 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TAMIFLU 30 MG CAPSULE?
Since Nov 28, 2013, the NADAC for TAMIFLU 30 MG CAPSULE has ranged from a low of $9.4158 (Jun 18, 2014) to a high of $13.4165 (Mar 13, 2019), with a median of $12.6454 per EA.
Are there cheaper alternatives to TAMIFLU 30 MG CAPSULE?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, OSELTAMIVIR PHOS 30 MG CAPSULE, is $0.7127 per EA — about 95% below TAMIFLU 30 MG CAPSULE.
Who manufactures TAMIFLU 30 MG CAPSULE?
TAMIFLU 30 MG CAPSULE (NDC 00004080285) is labeled by Genentech, Inc., and CMS classifies it as a brand product.